<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04165057</url>
  </required_header>
  <id_info>
    <org_study_id>108-084-F</org_study_id>
    <nct_id>NCT04165057</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Optimal Muscle Tension Management During Laparoscopic Cholecystectomy</brief_title>
  <official_title>Efficacy and Safety of Optimal Muscle Tension Management During Laparoscopic Cholecystectomy - a Prospective Randomized Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital Hsin-Chu Branch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital Hsin-Chu Branch</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study is intended to compare optimal muscle tension management or conventional anesthetic
      management in laparoscopic cholecystectomy about surgical condition during the surgery and
      other conditions after surgery at POR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is intended to recruit 70 patients undergoing laparoscopic cholecystectomy, whom
      will be randomized to receive optimal muscle tension management or conventional anesthetic
      management without optimal muscle tension management. Our primary hypothesis is that optimal
      muscle tension management provides improved surgical conditions and less intra-abdominal
      pressure required. The secondary endpoints include surgical duration, intraoperative
      complications, total amount of muscle relaxants, respiratory and hemodynamic changes during
      surgery, extubation time and any events during post-anesthetic recovery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Single Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical condition</measure>
    <time_frame>5 minutes</time_frame>
    <description>Surgeon describe CO2 inflation condition by 4 point King Score (1-4).
excellent
good
acceptable
poor or unacceptable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak inspiratory pressure during surgery</measure>
    <time_frame>1 hour</time_frame>
    <description>Peak inspiratory pressure during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean blood pressure</measure>
    <time_frame>Every 5 mins</time_frame>
    <description>Mean blood pressure during the CO2 inflation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total surgical time</measure>
    <time_frame>1 hour</time_frame>
    <description>Total surgical time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Rocuronium doses during surgery</measure>
    <time_frame>1 hour</time_frame>
    <description>Total Rocuronium doses during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score at Postoperative room</measure>
    <time_frame>1 hour</time_frame>
    <description>describe by 11 points Numeric rating scales (0-10). From 0 which means &quot;no pain&quot; to 10 means &quot;worst pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>every 5 mins</time_frame>
    <description>Every beat per minutes heart rate during CO2 inflation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory complications</measure>
    <time_frame>Every 5 mins</time_frame>
    <description>Record any respiratory complications including desaturations (&lt;95%, more than 30 seconds, Rispiratory rate &lt; 8), aspiration or airway obstruction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group OMT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Optimal muscle tension management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional anesthetic management</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optimal muscle tension management</intervention_name>
    <description>including TOF monitor and reversal of neuromuscular blockade agent : sugammadex</description>
    <arm_group_label>Group OMT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 20~80 years old

          -  ASA score : 1-2

          -  Regular laparoscopic cholecystectomy

        Exclusion Criteria:

          -  Renal function impairement (eGFR &lt; 60 ml/min/1.73m2) or ESRD

          -  BMI &lt; 18.5 kg/m2 or &gt;30 kg/m2

          -  History of other abdominal surgery

          -  Allergy to rocuronium, cisatracurium, neostigmine or sugammadex

          -  Emergent surgery

          -  Convert to open cholecystectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MING-HUI HUNG, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Taiwan University Hospital Hsinchu Branch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>YI-PING WANG, MD</last_name>
    <phone>+886-3-5326151</phone>
    <phone_ext>3900</phone_ext>
    <email>joesph0502@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital, Hsin-Chu Branch</name>
      <address>
        <city>Hsinchu</city>
        <zip>300</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>YI-PING WANG, MD</last_name>
      <phone>+886-3-5326151</phone>
      <phone_ext>3900</phone_ext>
      <email>joesph0502@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 3, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2019</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Optimal muscle tension</keyword>
  <keyword>Neuromuscular monitoring</keyword>
  <keyword>Neuromuscular blockade</keyword>
  <keyword>Sugammadex</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

